Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish …
M Maciorowska, B Uziębło-Życzkowska… - Polish Heart …, 2024 - journals.viamedica.pl
Background: Despite its benefits, oral anticoagulant (OAC) therapy in patients with atrial
fibrillation (AF) is associated with hemorrhagic complication s. Aims: We aimed to evaluate …
fibrillation (AF) is associated with hemorrhagic complication s. Aims: We aimed to evaluate …
Impact of previous stroke on clinical outcome in elderly patients with nonvalvular atrial fibrillation: ANAFIE registry
T Yoshimoto, K Toyoda, M Ihara, H Inoue, T Yamashita… - Stroke, 2022 - Am Heart Assoc
Background: We determined the long-term event incidence among elderly patients with
nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and …
nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and …
[HTML][HTML] Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation
MG Abrignani, A Lombardo, A Braschi… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …
[HTML][HTML] Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study
T Ikeda, T Yamashita, M Akao, H Atarashi… - Journal of …, 2023 - Elsevier
Background Elderly patients with atrial fibrillation (AF) are at a higher risk for all-cause
mortality and heart failure. Rate control is an essential component in AF management. This …
mortality and heart failure. Rate control is an essential component in AF management. This …
Anticoagulantion Therapy for Non-Valvular Atrial Fibrillation.
A Kamendu, A Singh, PD Dilipbhai, T Anwar… - European Journal of …, 2022 - go.gale.com
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia accounting for
one-third of all arrhythmia related hospitalizations. AF is major risk factor for stroke. Atrial …
one-third of all arrhythmia related hospitalizations. AF is major risk factor for stroke. Atrial …